a16z Podcast: The Economics of Expensive Medicines
The a16z Show30 Mai 2019

a16z Podcast: The Economics of Expensive Medicines

with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio)

The advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold before. In this episode, MIT economist Andrew Lo and a16z General Partner on the Bio Fund Jorge Conde discuss how exactly we place an economic value on a cure; the questions we still need to figure out, like who should pay for what and how; and how we need to start thinking about handling the coming influx of highly priced medicines like these into our healthcare system.

If we think about these payments as a kind of 'mortgage for a cure,' what happens when your gene therapy mortgage defaults? How would payment plans like these move between insurance plans? Lo and Conde also discuss the broader context in our healthcare system, the economics and risk of drug discovery and development overall – and finally, how our markets might just function more like biological systems than anything else.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(1000)

Who Controls AI Acceleration? Vitalik Buterin and Guillaume Verdon Debate

Who Controls AI Acceleration? Vitalik Buterin and Guillaume Verdon Debate

Eddy Lazzarin speaks with Vitalik Buterin, founder of Ethereum, and Guillaume Verdon, founder and CEO of Extropic, about whether AI progress can or should be steered, the risks of concentrated power, ...

9 Apr 1h 39min

The Agent Era: Building Software Beyond Chat with Box CEO Aaron Levie

The Agent Era: Building Software Beyond Chat with Box CEO Aaron Levie

Erik Torenberg, Steve Sinofsky, and Martin Casado speak to Aaron Levie, CEO at Box, about what happens to enterprise software when agents become the primary users. They discuss why coding agents succe...

8 Apr 59min

Balaji on Why AI Raises the Cost of Verification

Balaji on Why AI Raises the Cost of Verification

a16z general partner Erik Torenberg speaks with Balaji Srinivasan, angel investor and entrepreneur, about why AI simultaneously reduces the cost of creation and increases the cost of verification, and...

7 Apr 1h 7min

Peter Yang on Small Teams, Coding Agents, and Why Human Ambition Has No Ceiling

Peter Yang on Small Teams, Coding Agents, and Why Human Ambition Has No Ceiling

Anish Acharya speaks with Peter Yang, creator and product lead at Roblox, about how personal AI agents are replacing the apps we open every day, why coding agents feel like slot machines, and what hap...

6 Apr 28min

Marc Andreessen on AI Winters and Agent Breakthroughs

Marc Andreessen on AI Winters and Agent Breakthroughs

This episode originally aired on the Latent Space Podcast. swyx and Alessio Fanelli speak with Marc Andreessen about the arc of AI from its origins in 1943 to today's breakthroughs in reasoning, codin...

3 Apr 1h 17min

Alex Blania on Proof of Human and Building World's Identity Network

Alex Blania on Proof of Human and Building World's Identity Network

a16z's Ben Horowitz and Erik Torenberg speak with Alex Blania, cofounder and CEO of Tools for Humanity, World, and cofounder of Merge Labs. World is building the largest real human network, a proof-of...

2 Apr 42min

What Happens When a Public Company Goes All In on AI

What Happens When a Public Company Goes All In on AI

David Haber speaks with Owen Jennings, executive officer and business lead at Block, about how the company rebuilt itself around AI agents, small squads, and internal tools like Goose and Builder Bot ...

1 Apr 27min

How Radiant and Heron Are Rethinking Power Generation and Delivery

How Radiant and Heron Are Rethinking Power Generation and Delivery

a16z general partners Erin Price-Wright and Erik Torenberg speak with Doug Bernauer, founder and CEO of Radiant, and Drew Baglino, founder and CEO of Heron, about rebuilding American energy infrastruc...

31 Mar 49min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
pengesnakk
livet-pa-veien-med-jan-erik-larssen
utbytte
rss-pa-konto
pengepodden-2
finansredaksjonen
morgenkaffen-med-finansavisen
liberal-halvtime
tid-er-penger-en-podcast-med-peter-warren
stormkast-med-valebrokk-stordalen
lederpodden
rss-markedspuls-2
okonomiamatorene
rss-sunn-okonomi